Evidence map›Paper›PMID 41226172›Full record

ReviewMolecules (Basel, Switzerland)2025

Cyclophane-Based Dendrimers: Today and Tomorrow.

Olga Mostovaya, Alena Vavilova, Asiya Gazizova, Ivan Stoikov

Abstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Olga MostovayaA.M. Butlerov Chemical Institute, Kazan Federal University, Kremlevskaya St., 18, 420008 Kazan, Russia.
Alena VavilovaA.M. Butlerov Chemical Institute, Kazan Federal University, Kremlevskaya St., 18, 420008 Kazan, Russia.
Asiya GazizovaA.M. Butlerov Chemical Institute, Kazan Federal University, Kremlevskaya St., 18, 420008 Kazan, Russia.
Ivan StoikovA.M. Butlerov Chemical Institute, Kazan Federal University, Kremlevskaya St., 18, 420008 Kazan, Russia.ORCID 0000-0002-3019-7866

Funding

Russian Science Foundation 21-73-20067-P
6 · The paper itself

Abstract

For decades, dendrimers have attracted the great interest of researchers, and continue to do so to this day. These compounds found a wide variety of applications in such areas as medicine, catalysis, and electronics. However, their synthesis is very expensive, and purification and isolation are difficult. In addition, dendrimers are often highly toxic. Toxic properties are significantly dependent on the generation and terminal group features. For the toxicity, decreasing the modification of dendrimer structure is widely used. This review discusses some examples of constructing dendrimers based on macrocyclic compounds-cyclophanes (pillararenes, resorcinarenes, and (thia)calixarenes). Preparation of these hybrids is not very difficult, and due to the presence of a hydrophobic macrocyclic platform, they acquire a number of practically useful properties that are not available to traditional dendrimers, such as additional opportunities for encapsulating substrates. Moreover, dendrimers acquire amphiphilic and chiral properties. This review is devoted to the features of the synthesis and properties of macrocyclic dendrimers based on cyclophanes. The review also demonstrates the prospects of using the resulting dendrimers for medicine, sensorics, catalysis and alternative energy sources.

Indexed as

applicationdendrimersdrug deliverypillararenesresorcinarenessynthesis(thia)calixarenes

Identifiers

PMID41226172
PMCPMC12608753

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.